Dexterra Group Inc.
TSX:DXT.TOSpecialty Business Services
+$0.02 today
- Market cap
- $1.18B
- Beta
- 0.65
- P/E (TTM)
- 17.8
- EPS (TTM)
- $0.73
- Dividend yield
- 2.99%
Volume 0.06M
Average 0.03M
DXT.TO EBITDA
Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.
Dexterra Group Inc.TSX: DXT.TO
EBITDA · Q1 FY2026 · quarter ended Mar 2026
EBITDA growth accelerates
Q1 FY2026 EBITDA of CA$28.88M rose 25.5% year over year, ahead of the +6.3% change in trailing-twelve-month EBITDA. Sequentially, it rose 13.2% from the prior quarter. Over 3 fiscal years it compounded at +19.0% a year.
Context
- EBITDA amounted to 10.3% of revenue in FY2025, up 0.1 pp from a year earlier.
- EBITDA increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether EBITDA reaches the consensus estimate from 7 analysts of CA$120.96M (+13.0%) for the fiscal year ending Dec 2026, a step up from the +5.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- CA$28.88M+13.2% QoQ
- Last fiscal yearDec 2025
- CA$107.02M+5.0% YoY
- LTMMar 2026
- CA$113.74M+6.3% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +25.5% | +10.4% | -15.1 pp |
| 1 year | +5.0% | +13.0% | +8.0 pp |
| 3-year CAGR | +19.0% | +6.0% | -13.0 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EBITDA history
CAD · from the income statement
- Latest · FY2025
- 107.02M CAD
- Year-over-year change
- +5.0%
- 4-year CAGR
- +9.7%
| Period | Period end | EBITDA | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 107.02M | +5.0% |
| FY2024 | 2024-12-31 | 101.9M | +8.5% |
| FY2023 | 2023-12-31 | 93.96M | +48.1% |
| FY2022 | 2022-12-31 | 63.44M | -14.3% |
| FY2021 | 2021-12-31 | 74.02M | — |
EBITDA vs competitors
How DXT.TO compares with its peers on the latest reported figures
- Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +6.3% is the 8th highest of 9, against a peer median of +20.6%.
- EBITDA amounts to 10.6% of revenue for DXT.TO, versus a peer median of 14.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | CA$208.36M CAD | +16.4% | -14.8% | 16.1% | |
| LTM Mar 2026 | CA$191.37M CAD | +24.5% | +2.4% | 9.1% | |
| LTM Mar 2026 | $183.48M USD | +11.1% | -25.4% | 8.1% | |
| LTM Mar 2026 | CA$175.9M CAD | +25.3% | -3.7% | 22.5% | |
| LTM Mar 2026 | CA$161.17M CAD | -4.3% | +27.1% | 11.4% | |
| LTM Mar 2026 | CA$113.74M CAD | +6.3% | +19.0% | 10.6% | |
| LTM Mar 2026 | CA$100.44M CAD | +44.4% | +34.8% | 18.1% | |
| LTM Mar 2026 | CA$99.81M CAD | +88.4% | +13.0% | 12.0% | |
| LTM Mar 2026 | CA$64.32M CAD | +16.7% | +24.8% | 88.5% | |
| Peer median (excluding DXT.TO) | — | +20.6% | +7.7% | 14.0% | |
Competitors are the stored peer set for DXT.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 733.38M | 971.52M | 1.12B | 1B | 1.04B |
| Cost of Revenue | 622.84M | 880.97M | 786.75M | 843M | 896.98M |
| Gross Profit | 110.54M | 90.55M | 141.02M | 160.03M | 144.27M |
| Gross Margin | 15.1% | 9.3% | 12.6% | 16.0% | 13.9% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 37.15M | 42.22M | 43.92M | 58.08M | 79.6M |
| Operating Expenses | 74.59M | 80.82M | 82.04M | 92.93M | 79.6M |
| Depreciation & Amortization | 38.06M | 38.61M | 34.98M | 35.21M | 42.34M |
| EBITDA | 74.02M | 63.44M | 93.96M | 101.9M | 107.02M |
| EBITDA Margin | 10.1% | 6.5% | 8.4% | 10.2% | 10.3% |
| Operating Income | 35.96M | 10.15M | 58.99M | 67.1M | 64.67M |
| Operating Margin | 4.9% | 1.0% | 5.3% | 6.7% | 6.2% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 5.1M | 8.95M | 13.44M | 13.06M | 11.34M |
| Other Income / Expenses | (2.62M) | (6.93M) | (11.48M) | (13.46M) | (9.98M) |
| Income Before Tax | 33.34M | 3.22M | 47.5M | 53.64M | 54.69M |
| Pre-Tax Margin | 4.5% | 0.3% | 4.3% | 5.3% | 5.3% |
| Income Tax Expense | 8.71M | (495K) | 11.69M | 16.1M | 13.89M |
| Net Income | 24.36M | 3.43M | 26.62M | 19.87M | 40.51M |
| Net Margin | 3.3% | 0.4% | 2.4% | 2.0% | 3.9% |
| EPS (Basic) | 0.37 | 0.05 | 0.41 | 0.31 | 0.65 |
| EPS (Diluted) | 0.37 | 0.05 | 0.41 | 0.31 | 0.64 |
| Weighted Avg Shares | 65.82M | 65.21M | 64.99M | 64.02M | 62.42M |
| Weighted Avg Shares (Diluted) | 65.42M | 65.49M | 65.22M | 64.3M | 63.36M |
Dexterra Group Inc.
TSX:DXT.TO
Intrinsic Alpha fair value
Locked
Current Price
$18.83
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.